155 related articles for article (PubMed ID: 16927796)
21. Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young.
Koo JS; Hong S; Park CS
Thyroid; 2009 Nov; 19(11):1225-31. PubMed ID: 19888860
[TBL] [Abstract][Full Text] [Related]
22. Detection of metastatic cervical lymph nodes in recurrent papillary thyroid carcinoma: computed tomography versus positron emission tomography-computed tomography.
Lee DH; Kang WJ; Seo HS; Kim E; Kim JH; Son KR; Na DG
J Comput Assist Tomogr; 2009; 33(5):805-10. PubMed ID: 19820516
[TBL] [Abstract][Full Text] [Related]
23. Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection.
Chung YS; Kim JY; Bae JS; Song BJ; Kim JS; Jeon HM; Jeong SS; Kim EK; Park WC
Thyroid; 2009 Mar; 19(3):241-6. PubMed ID: 19265495
[TBL] [Abstract][Full Text] [Related]
24. Features of lymph node metastasis of papillary thyroid carcinoma in ultrasonography and CT and the significance of their combination in the diagnosis and prognosis of lymph node metastasis.
Wei Q; Wu D; Luo H; Wang X; Zhang R; Liu Y
J BUON; 2018; 23(4):1041-1048. PubMed ID: 30358209
[TBL] [Abstract][Full Text] [Related]
25. Galectin-3 expression in papillary thyroid carcinoma: relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size.
Cvejic DS; Savin SB; Petrovic IM; Paunovic IR; Tatic SB; Havelka MJ
Head Neck; 2005 Dec; 27(12):1049-55. PubMed ID: 16155918
[TBL] [Abstract][Full Text] [Related]
26. Regional lymph node involvement in T1 papillary thyroid carcinoma: a bicentric prospective SPECT/CT study.
Mustafa M; Kuwert T; Weber K; Knesewitsch P; Negele T; Haug A; Linke R; Bartenstein P; Schmidt D
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1462-6. PubMed ID: 20358197
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological profile of papillary carcinoma of thyroid: A 10-year experience in a tertiary care institute in North Karnataka, India.
Rao R; Giriyan SS; Rangappa PK
Indian J Cancer; 2017; 54(3):514-518. PubMed ID: 29798949
[TBL] [Abstract][Full Text] [Related]
28. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
29. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma.
Nahas Z; Goldenberg D; Fakhry C; Ewertz M; Zeiger M; Ladenson PW; Wahl R; Tufano RP
Laryngoscope; 2005 Feb; 115(2):237-43. PubMed ID: 15689742
[TBL] [Abstract][Full Text] [Related]
30. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
Wang T; Jiang CX; Li Y; Liu X
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
[TBL] [Abstract][Full Text] [Related]
31. Papillary thyroid carcinoma of a diffuse sclerosing variant: ultrasonographic monitoring from a normal thyroid gland to mass formation.
Kim HS; Han BK; Shin JH; Ko EY; Sung CO; Oh YL; Song SY
Korean J Radiol; 2010; 11(5):579-82. PubMed ID: 20808705
[TBL] [Abstract][Full Text] [Related]
32. Ultrasonographic characteristics of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma.
Liu MJ; Liu ZF; Hou YY; Men YM; Zhang YX; Gao LY; Liu H
Oncotarget; 2017 Apr; 8(16):27520-27528. PubMed ID: 28460476
[TBL] [Abstract][Full Text] [Related]
33. Thyroid cancer in childhood: a retrospective review of childhood course.
O'Gorman CS; Hamilton J; Rachmiel M; Gupta A; Ngan BY; Daneman D
Thyroid; 2010 Apr; 20(4):375-80. PubMed ID: 20373982
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT.
Choi JW; Yoon YH; Yoon YH; Kim SM; Koo BS
Ann Surg Oncol; 2011 May; 18(5):1306-11. PubMed ID: 21140231
[TBL] [Abstract][Full Text] [Related]
35. An analysis of factors predicting lateral cervical nodal metastases in papillary carcinoma of the thyroid.
Hunt JP; Buchmann LO; Wang L; Abraham D
Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1141-5. PubMed ID: 22106241
[TBL] [Abstract][Full Text] [Related]
36. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
37. Impact of preoperative ultrasonographic staging of the neck in papillary thyroid carcinoma.
González HE; Cruz F; O'Brien A; Goñi I; León A; Claure R; Camus M; Dominguez F; Mosso L; Arteaga E; González G; López JM; Rodriguez JA; Carrasco C; Fardella C
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1258-62. PubMed ID: 18086969
[TBL] [Abstract][Full Text] [Related]
38. Two patients with highly aggressive macrofollicular variant of papillary thyroid carcinoma.
Cardenas MG; Kini S; Wisgerhof M
Thyroid; 2009 Apr; 19(4):413-6. PubMed ID: 19355832
[TBL] [Abstract][Full Text] [Related]
39. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
[TBL] [Abstract][Full Text] [Related]
40. Tall cell variant of papillary thyroid carcinoma: a population-based study in Iceland.
Axelsson TA; Hrafnkelsson J; Olafsdottir EJ; Jonasson JG
Thyroid; 2015 Feb; 25(2):216-20. PubMed ID: 25322334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
